In breast cancer, there was no significant difference in PD-L1 positivity between quartiles in the entire cohort (Figure 3A), and only a small, nonsignificant difference between Q1 (45%) and Q4 (40%) in TNBC (P = .06; Supplementary Figure S2). Here, CD274 is linked to breast carcinoma.